Updates on Inflammatory Molecular Pathways Mediated by ADAM17 in Autoimmunity
Author Information
Author(s): Sisto Margherita, Lisi Sabrina
Primary Institution: University of Bari “Aldo Moro”
Hypothesis
ADAM17 plays a crucial role in the regulation of autoimmune diseases through its involvement in various inflammatory pathways.
Conclusion
The review highlights the complex role of ADAM17 in autoimmune diseases and suggests that targeting its pathways may offer new therapeutic strategies.
Supporting Evidence
- ADAM17 is involved in the shedding of various substrates that are important in inflammation and autoimmunity.
- Recent studies have shown that ADAM17 is a key player in several autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus.
- Targeting ADAM17 may provide new therapeutic options for treating autoimmune conditions.
Takeaway
ADAM17 is like a helper in our body that can make things go wrong when it comes to diseases where our body attacks itself, and scientists are trying to find ways to stop it from causing problems.
Methodology
This is a review article summarizing recent findings on ADAM17's role in autoimmunity based on various studies.
Limitations
The review does not provide new experimental data but summarizes existing literature, which may not cover all recent developments.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website